Contact
QR code for the current URL

Story Box-ID: 65237

Speedel Pharma AG Hirschgässlein 11 4051 Basel, Switzerland http://www.speedel.com
Contact Ms Sharon Valdettaro +41 61 206 40 25
SP
Speedel Pharma AG

Neue Phase-III - Daten für den Reninhemmer SPP100 (Rasilez) bestätigen sein Potenzial bei der Behandlung von Diabetes-Patienten

Robuste Wirksamkeits- und Verträglichkeitsdaten am Meeting der European Society of Hypertension präsentiert

(PresseBox) (Basel/Schweiz und Bridgewater NJ/USA,, )
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.